13,459 Shares in SPDR S&P Biotech ETF $XBI Bought by Balefire LLC

Balefire LLC bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, Holdings Channel reports. The fund bought 13,459 shares of the exchange traded fund’s stock, valued at approximately $1,641,000.

Several other hedge funds have also modified their holdings of XBI. JPMorgan Chase & Co. boosted its position in shares of SPDR S&P Biotech ETF by 27.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after purchasing an additional 2,900,633 shares during the period. Bessemer Group Inc. raised its holdings in SPDR S&P Biotech ETF by 9.3% during the 3rd quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock worth $163,624,000 after buying an additional 138,322 shares during the period. Ameriprise Financial Inc. lifted its stake in SPDR S&P Biotech ETF by 40.5% during the third quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock valued at $122,906,000 after buying an additional 353,351 shares in the last quarter. Meitav Investment House Ltd. boosted its holdings in shares of SPDR S&P Biotech ETF by 70.3% in the third quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after buying an additional 281,602 shares during the period. Finally, Greenhouse Funds LLLP boosted its holdings in shares of SPDR S&P Biotech ETF by 16.6% in the third quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock worth $67,733,000 after buying an additional 96,308 shares during the period.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $119.54 on Wednesday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $132.09. The firm’s 50 day simple moving average is $125.24 and its 200-day simple moving average is $116.82. The company has a market cap of $7.99 billion, a P/E ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.